Financial News

Remedy Closes Series A Funding Round

Led by L Catterton, funds will support clinical research, product innovation, team expansion and expanded retail.

Remedy, the dermatologist-developed skincare brand, announced the closing of its Series A funding round led by L Catterton, with participation from existing investor Norwest and new investor Sonoma Brands Capital.

The funding will support clinical research, product innovation, team expansion and continued growth across DTC, Amazon and Target distribution.

Founded by board-certified dermatologist Dr. Muneeb Shah, Remedy’s skincare portfolio addresses the concerns dermatologists see every day including dark spots, dryness, fine lines, dullness, keratosis pilaris and sensitive skin.

Dr. Muneeb Shah

“For years, I saw patients who were doing everything right but still struggling to find products that delivered meaningful results without irritation or unnecessary complexity. Remedy was created to modernize dermatologist-developed skincare, said Dr. Muneeb Shah, founder and CEO of Remedy. “Each formula starts with a real patient need. We then innovate with the latest ingredient technologies to create clinically tested, high-efficacy formulas with a focus on visible results and safety for sensitive skin.”

L Catterton made Happi headlines this week with its Kiko Milano brand’s partnership with Madonna, as reported here.

Keep Up With Our Content. Subscribe To Happi Newsletters